[1] |
徐倩,周敏. 2019年《原发性免疫性血小板减少症的调查和管理:国际共识报告更新》儿童部分解读[J]. 中国实用儿科杂志,2021,36:86-89.
|
[2] |
Khalefa AA. Analysis of the expression profile of long non-coding RNAs MALAT1 and THRIL in children with immune thrombocytopenia (vol 72, pg 1941, 2020)[J]. IUBMB life, 2021,13:73-77.
|
[3] |
Harris EM, Hillier K, Al-Samkari H, et al. Characteri-stics of children and adults treated with rituximab for immune thrombocytopenia (ITP)[J]. Blood, 2020, 136:38-39.
|
[4] |
张爱军,刘芹芹,浦婷. 儿童免疫性血小板减少症的规范治疗与管理[J]. 临床儿科杂志,2022,40:81-86.
|
[5] |
Karthikraj T, Jenish RJ, Jeyabalaji RV, et al. Spectrum of febrile thrombocytopenia among children in a tropical country-a hospital based observational study in South India[J]. Int J Contemp Pediat, 2021, 8:354-357.
|
[6] |
Zhang JN, Zhao P, Liu K, et al. Risk and prognostic factors for intracranial hemorrhage in elderly patients with immune thrombocytopenia[J]. Blood, 2020, 136:14-15.
|
[7] |
Soboleva OA, Ntanisian KI, Egorova EK, et al. Imme-diate pre-splenectomy platelet count predicts splenectomy response in adult immune thrombocytopenia patients[J]. Blood, 2020, 136:11-13.
|
[8] |
倪鑫,申昆玲,沈颖.《诸福棠实用儿科学》(第八版)[M].北京:人民卫生出版社,2015:102-108.
|
[9] |
中国儿童原发性免疫性血小板减少症诊断与治疗指南改编工作组,中华医学会儿科学分会血液学组,中华儿科杂志编辑委员会. 中国儿童原发性免疫性血小板减少症诊断与治疗改编指南(2021版)[J]. 中华儿科杂志,2021,59:810-819.
|
[10] |
Guillet S, Loustau V, Zarour A, et al. Risk factors of neonatal immune thrombocytopenia in pregnant women previously diagnosed with ITP: results from a french nationwide prospective study[J]. Blood, 2020, 136:36-37.
|
[11] |
Suntsova EV, Chikvina II, Sadovskaya MN, et al. Use of romiplostim for newly diagnosed immune thrombocytopenia in children[J]. Pediat Hematol, 2020, 19:18-26.
|
[12] |
Kittivisuit S, Vachvanichsanong P, Mcneil E, et al. Childhood-onset systemic lupus erythematosus and immune thrombocytopenia: prevalence and risk factors[J].Pediatr Blood Cancer. 2021,68:29146-29149.
|
[13] |
Singh G, Bansal D, Wright N. Immune thrombocytopenia in children: consensus and controversies[J]. Indian J Pediatr, 2020, 87:150-157.
|
[14] |
Ignatova AA, Suntsova EV, Pshonkin AV, et al. Platelet function and bleeding at different phases of childhood immune thrombocytopenia[J]. Sci Rep,2021,11:9401-9407.
|
[15] |
Kyohei I, Makiko M, Tomoya I, et al. Thrombopoietin receptor agonists for pediatric refractory chronic immune thrombocytopenia[J]. Japan J Clin Hematol, 2021,62:1382-1387.
|
[16] |
Song Y, Zhang Y, Li Z, et al. Potential risk factors for the development from immune thrombocytopenia to systemic lupus erythematosus: a case-control study in Chinese children[J]. Ann Hematol, 2022,11:101-106.
|
[17] |
Badarayan KV, Oswal JS, Kapur SV. Immune thrombocytopenic purpura with psoriasis: a rare association in children[J]. Int J Contemp Pediat, 2021, 8:588-593.
|
[18] |
Schönborn L, Seck SE, Thiele T, et al. Long-term outcome in vaccine-induced immune thrombocytopenia and thrombosis[J]. J Thromb Haemost, 2023, 21: 2519-2527.
|
[19] |
Naleyev AA, Lazarev VV, Linkova TV. Anesthesia in children with thrombocytopenia during bypass surgery for extrahepatic portal hypertension (Review)[J]. General Reanimat, 2021, 17:88-102.
|
[20] |
Thau A, Saffren B, Zakrzewski H, et al. Retinal hemorrhage and bleeding disorders in children: a review[J]. Child Abuse Neglect, 2021, 112:104901-104907.
|